J. Goldman & CO LP Ardelyx, Inc. Call Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$5.28 - $7.57 $1.43 Million - $2.04 Million
270,000 New
270,000 $1.86 Million
Q4 2022

Feb 14, 2023
BUY
$1.22 - $2.85 $128,100 - $299,250
105,000 New
105,000 $299,000
Q3 2020

Nov 16, 2020
SELL
$5.25 - $7.08 $157,500 - $212,400
-30,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$5.37 - $8.11 $161,100 - $243,299
30,000 New
30,000 $208,000

Others Institutions Holding ARDX

# of Institutions
218
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $787M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email